142 related articles for article (PubMed ID: 21934122)
21. K+ current inhibition by amphiphilic fatty acid metabolites in rat ventricular myocytes.
Xu Z; Rozanski GJ
Am J Physiol; 1998 Dec; 275(6):C1660-7. PubMed ID: 9843728
[TBL] [Abstract][Full Text] [Related]
22. Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria.
Sayed-Ahmed MM; Shouman SA; Rezk BM; Khalifa MH; Osman AM; El-Merzabani MM
Pharmacol Res; 2000 Feb; 41(2):143-50. PubMed ID: 10623482
[TBL] [Abstract][Full Text] [Related]
23. The relationship between palmitoyl-coenzyme A synthetase activity and esterification of sn-glycerol 3-phosphate in rat liver mitochondria.
Sánchez M; Nicholls DG; Brindley DN
Biochem J; 1973 Apr; 132(4):697-706. PubMed ID: 4721605
[TBL] [Abstract][Full Text] [Related]
24. Fatty acid metabolism in hearts containing elevated levels of CoA.
Lopaschuk GD; Hansen CA; Neely JR
Am J Physiol; 1986 Mar; 250(3 Pt 2):H351-9. PubMed ID: 3953832
[TBL] [Abstract][Full Text] [Related]
25. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.
Abdul-Ghani MA; Muller FL; Liu Y; Chavez AO; Balas B; Zuo P; Chang Z; Tripathy D; Jani R; Molina-Carrion M; Monroy A; Folli F; Van Remmen H; DeFronzo RA
Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E678-85. PubMed ID: 18593850
[TBL] [Abstract][Full Text] [Related]
26. The effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carbonyl-Co-A on mitochondrial oxidations.
Turnbull DM; Bartlett K; Younan SI; Sherratt HS
Biochem Pharmacol; 1984 Feb; 33(3):475-81. PubMed ID: 6704164
[TBL] [Abstract][Full Text] [Related]
27. The relationship between palmitoyl-coenzyme A synthetase activity and esterification of sn-glycerol 3-phosphate by the microsomal fraction of guinea-pig intestinal mucosa.
Brindley DN
Biochem J; 1973 Apr; 132(4):707-15. PubMed ID: 4721606
[TBL] [Abstract][Full Text] [Related]
28. Increased fatty acid uptake and altered fatty acid metabolism in insulin-resistant muscle of obese Zucker rats.
Turcotte LP; Swenberger JR; Zavitz Tucker M; Yee AJ
Diabetes; 2001 Jun; 50(6):1389-96. PubMed ID: 11375340
[TBL] [Abstract][Full Text] [Related]
29. Factors to consider in using [U-C]palmitate for analysis of sphingolipid biosynthesis by tandem mass spectrometry.
Haynes CA; Allegood JC; Wang EW; Kelly SL; Sullards MC; Merrill AH
J Lipid Res; 2011 Aug; 52(8):1583-94. PubMed ID: 21586681
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise.
Holloway GP; Bezaire V; Heigenhauser GJ; Tandon NN; Glatz JF; Luiken JJ; Bonen A; Spriet LL
J Physiol; 2006 Feb; 571(Pt 1):201-10. PubMed ID: 16357012
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of carnitine palmitoyl-CoA transferase activity and fatty acid oxidation by lactate and oxfenicine in cardiac muscle.
Bielefeld DR; Vary TC; Neely JR
J Mol Cell Cardiol; 1985 Jun; 17(6):619-25. PubMed ID: 3927008
[TBL] [Abstract][Full Text] [Related]
32. Relationship between plasma free fatty acid, intramyocellular triglycerides and long-chain acylcarnitines in resting humans.
Kanaley JA; Shadid S; Sheehan MT; Guo Z; Jensen MD
J Physiol; 2009 Dec; 587(Pt 24):5939-50. PubMed ID: 19858228
[TBL] [Abstract][Full Text] [Related]
33. Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation.
Paul HS; Adibi SA
J Clin Invest; 1979 Aug; 64(2):405-12. PubMed ID: 457859
[TBL] [Abstract][Full Text] [Related]
34. Palmitoyl-carnitine production by blood cells associates with the concentration of circulating acyl-carnitines in healthy overweight women.
Chondronikola M; Asghar R; Zhang X; Dillon EL; Durham WJ; Wu Z; Porter C; Camacho-Hughes M; Zhao Y; Brasier AR; Volpi E; Sheffield-Moore M; Abate N; Sidossis L; Tuvdendorj D
Clin Nutr; 2017 Oct; 36(5):1310-1319. PubMed ID: 27624997
[TBL] [Abstract][Full Text] [Related]
35. Carnitine palmitoyltransferase I control of acetogenesis, the major pathway of fatty acid {beta}-oxidation in liver of neonatal swine.
Lin X; Shim K; Odle J
Am J Physiol Regul Integr Comp Physiol; 2010 May; 298(5):R1435-43. PubMed ID: 20237302
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone.
Foxworthy PS; Eacho PI
Biochem J; 1988 Jun; 252(2):409-14. PubMed ID: 3415664
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of palmitate oxidation in mitochondria by lipid hydroperoxides.
Imagawa T; Watanabe T; Nakamura T
J Biochem; 1984 Mar; 95(3):771-8. PubMed ID: 6725234
[TBL] [Abstract][Full Text] [Related]
38. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites.
Lee JS; Pinnamaneni SK; Eo SJ; Cho IH; Pyo JH; Kim CK; Sinclair AJ; Febbraio MA; Watt MJ
J Appl Physiol (1985); 2006 May; 100(5):1467-74. PubMed ID: 16357064
[TBL] [Abstract][Full Text] [Related]
39. Influence of malonyl-CoA and palmitate concentration on rate of palmitate oxidation in rat muscle.
Merrill GF; Kurth EJ; Rasmussen BB; Winder WW
J Appl Physiol (1985); 1998 Nov; 85(5):1909-14. PubMed ID: 9804598
[TBL] [Abstract][Full Text] [Related]
40. Controlling skeletal muscle CPT-I malonyl-CoA sensitivity: the importance of AMPK-independent regulation of intermediate filaments during exercise.
Miotto PM; Steinberg GR; Holloway GP
Biochem J; 2017 Feb; 474(4):557-569. PubMed ID: 27941154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
